Gilead Sciences was founded in 1987, which means it has been in operation for over thirty-five years. Since its inception, the company has focused on researching and developing innovative medicines, particularly in the fields of antiviral therapies for diseases such as HIV, hepatitis B, hepatitis C, and influenza. Over the years, Gilead has grown significantly and has expanded its portfolio to include treatments for oncology, inflammatory diseases, and other serious conditions. Its commitment to scientific research and patient care has positioned Gilead as a leader in the biotechnology and pharmaceutical industries. If you are interested in more detailed historical information or specific milestones in Gilead's timeline, you might consider visiting their official website to explore additional resources.